Description
MLN2480 is an oral pan-Raf inhibitor designed to inhibit cell proliferation and survival. MLN2480 is currently in clinical trials and displays anticancer chemotherapeutic activity.
| Product Unit Size | Cost | Quantity | Stock |
|---|
MLN2480 is an oral pan-Raf inhibitor designed to inhibit cell proliferation and survival. MLN2480 is currently in clinical trials and displays anticancer chemotherapeutic activity.
| Cas No. | 1096708-71-2 |
|---|---|
| Purity | ≥98% |
| Formula | C17H12Cl2F3N7O2S |
| Formula Wt. | 506.30 |
| IUPAC Name | 2-[(1R)-1-[(6-amino-5-chloropyrimidine-4-carbonyl)amino]ethyl]-N-[5- chloro-4-(trifluoromethyl)pyridin-2-yl]-1,3-thiazole-5-carboxamide |
| Solubility | DMSO 100 mg/mL (197.51 mM) Ethanol 100 mg/mL (197.51 mM) Water Insoluble |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet | |
| Brochures |
http://clinicaltrials.gov/show/NCT01425008
Synthetic derivative of glycyrrhizin; connexin ...
Histamine H1 antagonist.
H+/K+ ATPase and Scpc phosphatase inhibitor.
Nucleoside (deoxyguanosine) analog; DNA chain t...
Natriuretic, vasodilatory peptide fragment; B1/...
MAGL inhibitor.
Tocopherol analog
RORα/γ inverse agonist.
CDK7 inhibitor
Endogenous cardiomodulatory peptide; NPR-B agon...
SIRT inhibitor.
NSAID; TRPA1 agonist, COX-2 inhibitor.
Toxin produced by Canarthis vesicatoria; PP1/2A...
Mycotoxin produced by Aspergillus; actin polyme...
Oxidized non-cylic hexose sugar.
Organosulfide found in Allium; cholesterol synt...
Polyketide; DNMT 1 inhibitor, RNA synthesis inh...
Efflux pump inhibitor
PI3K inhibitor.